Vaxcyte (PCVX)
(Delayed Data from NSDQ)
$76.06 USD
-0.88 (-1.14%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $76.08 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -1.00 |
EPS Last Quarter | -0.85 |
Last EPS Surprise | 23.42% |
ABR | 1.11 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.96 |
Next Year | -4.17 |
EPS (TTM) | -4.28 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.00 | -0.89 | -3.96 | -4.17 |
# of Estimates | 4 | 2 | 5 | 4 |
Most Recent Consensus | -1.00 | -0.90 | -3.92 | -3.31 |
High Estimate | -0.86 | -0.87 | -3.43 | -3.31 |
Low Estimate | -1.10 | -0.90 | -4.40 | -4.75 |
Year ago EPS | -0.70 | -0.91 | -4.14 | -3.96 |
Year over Year Growth Est. | -42.86% | 2.20% | 4.35% | -5.47% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.00 | -0.89 | -3.96 | -4.17 |
7 Days Ago | -1.00 | -0.89 | -3.96 | -4.17 |
30 Days Ago | -1.00 | -0.89 | -3.96 | -4.17 |
60 Days Ago | -0.95 | -0.91 | -4.18 | -4.51 |
90 Days Ago | -0.95 | -0.91 | -4.18 | -4.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.00 | -0.89 | -3.96 | -4.17 |
Zacks Consensus Estimate | -1.00 | -0.89 | -3.96 | -4.17 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.85 | -1.82 | -0.91 | -0.70 | NA |
Estimate | -1.11 | -0.90 | -0.79 | -0.67 | NA |
Difference | 0.26 | -0.92 | -0.12 | -0.03 | -0.20 |
Surprise | 23.42% | -102.22% | -15.19% | -4.48% | -24.62% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more